We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
(-0.68%)
Cap. Flow
-$636M
Cap. Flow
% of AUM
-11.06%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$125M |
| 2 |
CVD
COVANCE INC.
CVD
|
+$75.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$71.6M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$69.7M |
| 5 |
PepsiCo
PEP
|
+$52.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$72.3M |
| 2 |
NCR Voyix
VYX
|
+$64.1M |
| 3 |
Humana
HUM
|
+$64M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$63.4M |
| 5 |
TSMC
TSM
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.85% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Consumer Staples | 10.69% |
| 4 | Industrials | 10.3% |
| 5 | Technology | 8.48% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2014 Portfolio in Review
As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.
- UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
- UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
- UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
- UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
- UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
- UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
- UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.
Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.